“Federal Judge Dismisses Novo Nordisk’s Legal Challenge Against Florida Pharmacy Over Ozempic Copycat Claims”

A federal judge in Florida has ruled in favor of a compounding pharmacy in a dispute with Novo Nordisk Inc. over the sale of drugs alleged to be “essentially copies” of the pharmaceutical giant’s popular Ozempic and Wegovy weight loss medications. The court determined that the claims brought under a state statute were moot, preempted, and not legally viable, effectively ending the case. For further details on the ruling, visit the article on Law360.